Nanobiotix S.A.
NBTX | NASDAQ
$34.88
+$0.38 (+1.10%)
Sep 22, 2026, 11:23 AM ET · Market open
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | -39.27 | -1.92 | -6.10 | -2.09 | -5.26 | -9.79 |
PEG Ratio | 0.60 | -0.06 | 0.18 | -0.10 | 2.42 | 0.24 |
PS Ratio | 31.74 | -11.28 | 6.69 | 25.01 | 93.47 | 6.58K |
PB Ratio | -11.14 | -1.99 | -131.29 | -4.42 | 9.24 | 4.67 |
P/FCF Ratio | -27.70 | -6.42 | -18.90 | -3.21 | -8.22 | -11.91 |
P/OCF Ratio | -28.15 | -6.70 | -19.41 | -3.22 | -8.28 | -11.95 |
OCF/S Ratio | -112.75 | 168.41 | -34.46 | -776.88 | -1.13K | -55.08K |
Debt / Equity Ratio | -1.13 | -0.77 | -27.42 | -1.97 | 1.72 | 0.70 |
Quick Ratio | 1.09 | 1.04 | 1.75 | 1.30 | 2.61 | 6.58 |
Current Ratio | 1.09 | 1.04 | 1.75 | 1.38 | 2.53 | 6.58 |
Asset Turnover | 0.44 | -0.17 | 0.39 | 0.08 | 0.03 | 0 |
Interest Coverage | -1.04 | -8.46 | -3.35 | -8 | -78.36 | -109.39 |
Return on Equity | 28.36% | 103.70% | 2.15K% | 210.92% | -175.45% | -47.71% |
Return on Assets | -35.36% | -101.06% | -42.28% | -95.44% | -46.19% | -25.09% |
Return on Invested Capital | -74.29% | -510.16% | -54.60% | -176.94% | -71.90% | -30.39% |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
FCF Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | 100% | 100% | 100% | 79.38% | 100% | 100% |
Net Profit Margin | -80.83% | 586.89% | -109.64% | -1.19K% | -1.78K% | -67.25K% |
Pretax Profit Margin | -80.82% | 586.02% | -109.31% | -1.19K% | -1.78K% | -67.23K% |
Operating Profit Margin | -36.49% | 589.13% | -73.96% | -977.85% | -1.99K% | -72.86K% |
FCF Margin | -114.59% | 175.72% | -35.39% | -778.83% | -1.14K% | -55.29K% |
EBITDA Margin | -40.71% | 502.40% | -65.42% | -925.82% | -1.72K% | -62.99K% |
Add to Watchlist
Select watchlists to add or remove NBTX